The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are once again teaming up to hit home runs for prostate cancer research and encourage fans to “Keep Dad in the Game” as part of the yearly celebration of Father’s Day and annual Home Run Challenge.
This year Joe Torre, MLB’s Chief Baseball Officer, Hall of Famer and prostate cancer survivor, encourages baseball fans everywhere to support PCF’s efforts to end prostate cancer by delivering an important public service announcement, “to step up to the plate, help save lives and get one step closer to finding a cure.”
“Joe has been a great partner in our progress toward improved treatment outcomes and an eventual cure,” said PCF Founder and Chairman Mike Milken. “His work as well as those by MLB and all 30 Clubs has helped us raise more than $45 million for research programs that are saving thousands of lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7729251-pcf-and-mlb-prostate-home-run-challenge/
The Council of Community Clinics (CCC), a premier consortium of primary care organizations in Southern California, today announced its new name and branding, Health Center Partners, the new name for its subsidiary formerly known as Community Clinic Health Network, Health Quality Partners, and the launch of Integrated Health Partners. Integrated Health Partners is a fully integrated primary health network designed to advance standards of care, improve outcomes and reduce costs for member community health centers. On the heels of its recently augmented executive leadership team and the addition of new member Community Health Systems, Inc., Health Center Partners today unveiled its innovative vision for meeting the evolving health needs of nearly 800,000 low-income and uninsured Californians at a launch ceremony in San Diego.
To view the multimedia release go to:
http://www.multivu.com/players/English/7774351-health-center-partners-unveils-community-health-vision/
Altimetrik, a business transformation and technology solutions company is unveiling advanced IoT solutions that are set to revolutionize the manufacturing industry.
Manufacturing industry is faced with the challenge of digitally connecting its assets with systems and people, engineering and acting upon the data on the floor to achieve predictive maintenance, precision monitoring & remote management. Altimetrik's Enterprise IoT capabilities make operational intelligence real by connecting machine data to newer business insights & driving meaningful outcomes. Altimetrik has made significant investments in creating IoT specific Research & Innovation Labs which’ve helped the company become a frontrunner in IoT consulting and execution. Altimetrik has been identified among leading IoT solution providers for manufacturing by IDC
Altimetrik is among the new breed of technology companies driving its business model based on the three global mega trends of modernization – Digital, Connected Solutions and Consumer Technologies.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7772051-altimetrik-future-of-enterprise-internet/
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and minimal access surgical approaches that deliver optimal clinical and aesthetic outcomes for patients. As part of the company’s broader women’s health initiative, Invuity is hosting a Hidden Scar Breast Cancer Surgery training course in advance of the American College of Surgeons (ACS) Clinical Congress.
Invuity aims to transform the surgical treatment of breast cancer with this advanced surgical approach for nipple sparing mastectomies and lumpectomies (breast conserving surgery). Hidden Scar Breast Cancer Surgery expands surgical options for patients, offering superior cosmetic outcomes that can improve their psychological and emotional recovery and enhance quality of life after surgery.1
With growing demand for less invasive alternatives to breast cancer surgery, surgeons need to operate through smaller incisions with limited fields of vision. Invuity’s illumination technology allows surgeons to access and visualize the entire breast cavity through discrete incision locations, enabling surgeons to safely and effectively treat breast cancer while preserving the natural shape of the breast and thereby minimizing and hiding the scars.
To view the multimedia release go to:
http://www.multivu.com/players/English/7644051-invuity-hidden-scar-breast-cancer-surgery-program/
The European Head and Neck Society (EHNS) and the Make Sense Campaign, today announced the launch of the Third Annual Head and Neck Cancer Awareness week (21–25 September). Through the pan-European Awareness Week, the EHNS and Make Sense Campaign promote education on head and neck cancer risk factors, disease prevention and disease signs and symptoms for both patients and healthcare professionals.
“Each year 350,000 people are diagnosed with head and neck cancer across Europe, and over half will not be alive after five years. However, if diagnosed and treated earlier, patients can have an 80 – 90% survival rate.” said Professor René Leemans, President of the EHNS and Professor and Chief of Otolaryngology – Head and Neck Surgery at VU University Medical Centre. “Through the Make Sense Campaign we are educating people about the early signs of the disease and encouraging them to seek professional help in a timely manner. Additionally, we are advocating for the best possible standards of patient care so that their outcomes can be optimised once they have been diagnosed with the disease.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7628151-support-head-neck-cancer-patients/
West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC, today announced the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient-engagement platform with West’s injectable drug delivery systems to provide an end-to-end connected health solution for pharmaceutical companies and the patients they serve. The combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication. The HealthPrize system engages and educates patients to increase adherence and medical literacy, rewarding interaction and compliance with prescribed treatment plans, and contributing to better health outcomes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7625851-west-pharma-healthprize-tech-collaboration/
Honeywell (NYSE:HON) today announced the next generation of smart building technology, Command and Control Suite, which turns complex facility data into recommendations and easy-to-implement changes that help boost business outcomes — lowering costs, minimizing risk and reducing downtime.
By combining intelligent automation, advanced analytics and visualization with the simplified user experience of today‘s home and mobile electronics, Command and Control Suite links building automation and the enterprise. It can provide a holistic view of a connected building‘s video feeds, access control and fire alarms, for example, and pull in relevant information from human resource applications. Integrating data from these disparate systems could help security personnel track occupants and make sure they exit the facility in the event of an evacuation, improving employee safety.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7525451-honeywell-command-and-control-suite/
A group of four minivans recently tested by the Insurance Institute for Highway Safety for protection in small overlap front crashes shows some of the worst possible outcomes for this type of crash, with only one vehicle performing acceptably.
The Nissan Quest, the Chrysler Town & Country and its twin, the Dodge Grand Caravan, all earn poor ratings. The exception to the disappointing pattern is the 2015 Toyota Sienna, which earns an acceptable rating. It joins the Honda Odyssey, which last year earned a good rating in the test, in the ranks of TOP SAFETY PICK+ winners.
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
Cochlear Limited, the global leader in implantable hearing solutions, has announced the launch of Nucleus® 6 in India, its next generation cochlear implant sound processor.
Nucleus 6 delivers industry first innovations designed to provide superior outcomes in a way that makes hearing a lot easier for the recipient – in the smallest sound processor on the market.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63489-cochlear-announces-nucleus-6-system
Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
